P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA

BACKGROUND: Neoadjuvant chemotherapy for patients with high-grade osteosarcoma has highly improved the clinical survival. However, the prognostic and predictive role of P16 expression after neoadjuvant chemotherapy remains unclear. We first determined whether P16 expression can become a potential pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yin, Yang, Changchun, Guo, Zonghui, Fu, Youwei, Yu, Xiao, Liu, Binggen, Zhou, Haier, Wang, Junjie, Li, Weilong, Pang, Qingjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428582/
https://www.ncbi.nlm.nih.gov/pubmed/28489748
http://dx.doi.org/10.1097/MD.0000000000006714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428582/
https://www.ncbi.nlm.nih.gov/pubmed/28489748
http://dx.doi.org/10.1097/MD.0000000000006714

Ejemplares similares